Like the current study, previous studies have found a positive association between age and plasma GFAP levels in patients with AD [9] and frontotemporal dementia (FTD) [28] and higher plasma GFAP levels in females compared to males were observed in patients with AD [9] and TBI [29]. This evidence concerns the gene GFAP and Alzheimer disease.